World Investment Advisors purchased a new position in shares of Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report) during the 4th quarter, Holdings Channel reports. The institutional investor purchased 41,326 shares of the company’s stock, valued at approximately $1,169,000.
A number of other hedge funds have also recently modified their holdings of the business. Steward Partners Investment Advisory LLC purchased a new stake in shares of Columbia Research Enhanced Value ETF in the 4th quarter worth $37,000. Private Advisor Group LLC purchased a new position in Columbia Research Enhanced Value ETF during the third quarter valued at $448,000. Essex Financial Services Inc. lifted its position in Columbia Research Enhanced Value ETF by 108.5% during the fourth quarter. Essex Financial Services Inc. now owns 24,626 shares of the company’s stock valued at $697,000 after purchasing an additional 12,815 shares in the last quarter. Commonwealth Equity Services LLC grew its holdings in Columbia Research Enhanced Value ETF by 14.8% during the fourth quarter. Commonwealth Equity Services LLC now owns 24,788 shares of the company’s stock valued at $701,000 after purchasing an additional 3,191 shares during the period. Finally, Ruggaard & Associates LLC grew its holdings in Columbia Research Enhanced Value ETF by 4.9% during the fourth quarter. Ruggaard & Associates LLC now owns 52,103 shares of the company’s stock valued at $1,474,000 after purchasing an additional 2,452 shares during the period.
Columbia Research Enhanced Value ETF Price Performance
Shares of REVS opened at $31.63 on Monday. The business has a 50-day simple moving average of $30.92 and a two-hundred day simple moving average of $29.68. The stock has a market cap of $291.00 million, a price-to-earnings ratio of 16.41 and a beta of 0.80. Columbia Research Enhanced Value ETF has a 52 week low of $25.55 and a 52 week high of $32.21.
Columbia Research Enhanced Value ETF Company Profile
The Columbia Research Enhanced Value ETF (REVS) is an exchange-traded fund that mostly invests in large cap equity. The fund tracks an index of US stocks pulled from the Russell 1000 Value Index. REVS index uses multifactor selection and market cap weighting. REVS was launched on Sep 25, 2019 and is managed by Columbia.
Recommended Stories
- Five stocks we like better than Columbia Research Enhanced Value ETF
- 3 Inflation-Fighting Stocks Built for Higher Oil Prices
- 3 Biotech Firms With Major Potential Catalysts in the Coming Months
- Applied Materials Stock Looks Pricey—Can AI Demand Justify the Rally?
- 3 Small-Cap Stocks Getting a Russell 2000 Rebalance Boost
Want to see what other hedge funds are holding REVS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Columbia Research Enhanced Value ETF (NYSEARCA:REVS – Free Report).
Receive News & Ratings for Columbia Research Enhanced Value ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Columbia Research Enhanced Value ETF and related companies with MarketBeat.com's FREE daily email newsletter.
